Are diabetic patients at increased risk of arrhythmias?

Hellenic Journal of Cardiology

Volumn 53, Issue 5, 2012, Pages 335-339

  Nakou, Eleni S ^a   Mavrakis, Hercules ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Arrhythmias; Diabetes

Indexed keywords

AUTONOMIC NEUROPATHY; CARDIOVASCULAR MORTALITY; DIABETES MELLITUS; EDITORIAL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE INJURY; HEART REPOLARIZATION; HUMAN; SCAR FORMATION; SILENT MYOCARDIAL ISCHEMIA; SUDDEN DEATH;

ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM; CONFIDENCE INTERVALS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEATH, SUDDEN, CARDIAC; DIABETIC NEUROPATHIES; ELECTROPHYSIOLOGICAL PROCESSES; HEART; HEART CONDUCTION SYSTEM; HUMANS; MYOCARDIAL ISCHEMIA; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 84866997678     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (36)

1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229-234.
2. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000; 102: 1014-1019.
3. Valensi P, Huard JP, Giroux C, Attali JR. Factors involved in cardiac autonomic neuropathy in diabetic patients. J Diabetes Complications. 1997; 11: 180-187.
4. Skrapari I, Tentolouris N, Katsilambros N. Baroreflex function: determinants in healthy subjects and disturbances in diabetes, obesity and metabolic syndrome. Curr Diabetes Rev. 2006; 2: 329-338.
5. Nesto RW, Libby P. Diabetes mellitus and the cardiovascular system. In Braunwald E, Zipes DP, Libby P (eds): Heart Disease. A textbook of cardiovascular Medicine. 6th ed. Philadelphia: WB Saunders; 2001. p 2133.
6. Gerritsen J, Dekker JM, TenVoorde BJ, et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care. 2001; 24: 1793-1798.
7. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2003; 24: 13-15.
8. Diakakis GF, Parthenakis FI, Mavrakis HE, et al. Association of impaired glucose tolerance with increased heart rate and subclinical inflammation. Hellenic J Cardiol. 2005; 46: 394-401.
9. Cardoso CR, Salles GF, Deccache W. Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study. J Diabetes Complications. 2003; 17: 169-178.
10. Schmid H, Forman LA, Cao X, Sherman PS, Stevens MJ. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocininduced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes. 1999; 48: 603-608.
11. Olgin JE, Sih HJ, Hanish S, et al. Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. Circulation. 1998; 98: 2608-2614.
12. Benjamin EJ, Levy D, Vaziri SM, DAgostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271: 840-844.
13. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98: 476-484.
14. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009; 373: 739-745.
15. Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care. 2009; 32: 1851-1856.
16. Aksnes TA, Schmieder RE, Kjeldsen SE, Ghani S, Hua TA, Julius S. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol. 2008; 101: 634-638.
17. Du X, Ninomiya T, de Galan B, et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J. 2009; 30: 1128-1135.
18. Camm AJ, Lip GY, De Caterina R, et al. Focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2012; Aug 24 (Epub ahead of print).
19. Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA. 2004; 292: 2495-2499.
20. Lee CD, Folsom AR, Pankow JS, Brancati FL. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004; 109: 855-860.
21. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001; 161: 1717-1723.
22. Lotufo PA, Gaziano JM, Chae CU, et al. Diabetes and allcause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001; 161: 242-247.
23. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002; 40: 954-960.
24. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998; 136: 205-212.
25. Albert CM, Chae CU, Grodstein F, et al. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003; 107: 2096-2101.
26. Curb JD, Rodriguez BL, Burchfiel CM, Abbott RD, Chiu D, Yano K. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation. 1995; 91: 2591-2595.
27. Balkau B, Jouven X, Ducimetière P, Eschwège E. Diabetes as a risk factor for sudden death. Lancet. 1999; 354: 1968-1969.
28. Jouven X, Lemaître RN, Rea TD, Sotoodehnia N, Empana JP, Siscovick DS. Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J. 2005; 26: 2142-2147.
29. Siscovick DS, Sotoodehnia N, Rea TD, Raghunathan TE, Jouven X, Lemaitre RN. Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community. Rev Endocr Metab Disord. 2010; 11: 53-59.
30. Jouven X, Desnos M, Guerot C, Ducimetière P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation. 1999; 99: 1978-1983.
31. Suhonen O, Reunanen A, Knekt P, Aromaa A. Risk factors for sudden and non-sudden coronary death. Acta Med Scand. 1988; 223: 19-25.
32. Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation. 1995; 91: 1749-1756.
33. Junttila MJ, Barthel P, Myerburg RJ, et al. Sudden cardiac death after myocardial infarction in patients with type 2 diabetes. Heart Rhythm. 2010; 7: 1396-1403.
34. Suarez GA, Clark VM, Norell JE, et al. Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry. 2005; 76: 240-245.
35. Rydén L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007; 28: 88-136.
36. Psallas M, Tentolouris N, Cokkinos A, Papadogiannis D, Cokkinos DV, Katsilambros N. QT dispersion: comparison between diabetic and non-diabetic individuals and correlation with cardiac autonomic neuropathy. Hellenic J Cardiol. 2006; 47: 255-262.